Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
6.67
+0.08 (1.29%)
At close: Jun 11, 2025, 4:00 PM
6.87
+0.21 (3.08%)
After-hours: Jun 11, 2025, 7:44 PM EDT
Quanterix Employees
Quanterix had 471 employees as of December 31, 2024. The number of employees increased by 30 or 6.80% compared to the previous year.
Employees
471
Change (1Y)
30
Growth (1Y)
6.80%
Revenue / Employee
$288,085
Profits / Employee
-$101,639
Market Cap
258.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
QTRX News
- 14 hours ago - Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders - PRNewsWire
- 5 days ago - Quanterix to Present at Goldman Sachs Global Healthcare Conference - Business Wire
- 19 days ago - Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal - PRNewsWire
- 4 weeks ago - Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Quanterix Releases Financial Results for the First Quarter of 2025 - Business Wire
- 5 weeks ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire
- 5 weeks ago - Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 - Business Wire
- 6 weeks ago - Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders - Business Wire